HEALTH

CADCA, CHPA honors Bucks County, Pa., with Dose of Prevention award

BY Michael Johnsen

WASHINGTON — The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association on Tuesday joined forces to honor the Bucks County, Pa.-based Bucks Promise for Youth and Communities with this year’s Dose of Prevention award. This award recognizes community-based organizations that have implemented successful initiatives to raise awareness of the dangers of prescription drug abuse and OTC cough medicine abuse.

“While prescription and over-the-counter medicines are safe and necessary for many people, too many teens are abusing these drugs to get high," stated Gen. Arthur Dean, CADCA chairman and CEO. "That’s why we’re glad to recognize Bucks Promise for Youth and Communities, which is utilizing a comprehensive approach to educate and address medicine abuse in their community.”

According to the "2012 Monitoring the Future Survey," 3% of eighth-graders, 4.7% of 10th-graders and 5.6% of 12th-graders have abused OTC cough medicines containing the active ingredient dextromethorphan to get high over the past year. Teens report getting many of these medicines from home medicine cabinets and mistakenly believe that abusing them is “safer” than other drugs. 

The survey also found that 21.2% of 12th-graders indicated using at least one prescription drug in their lifetime, without a doctor’s orders, while 14.8% indicated such use in the past year.

The Bucks Promise for Youth and Communities exemplifies the spirit of CADCA’s Dose of Prevention Award for its comprehensive approach to help raise awareness of the abuse of medicines in their community. They held a medicine take-back event to allow local residents to drop off unused, unwanted and expired medications and to educate the community about the dangers of medicine abuse. The group also held a town hall meeting to spur community discussions about medicine abuse and placed lock boxes throughout the county to allow for disposal of prescription medicines year round. Bucks Promise also worked with youth leaders to distribute nearly 8,000 brochures about the dangers of OTC cough medicine abuse to school nurses, school counselors and physical education teachers in schools throughout the county.

“Parents have the power to prevent OTC cough medicine abuse, and that prevention begins with educating parents and communities about this problem," said Scott Melville, CHPA president and CEO. "The efforts of the Bucks Promise for Youth and Communities demonstrate how local coalitions drive awareness, and we applaud their effort to bring this issue to the forefront in their community."

The group will receive its award on Feb. 7 during CADCA’s 23rd Annual National Leadership Forum, taking place Feb. 4 to 7, 2013, at the Gaylord National Hotel and Convention Center in National Harbor, Md.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

J&J chief: McNeil will work to reclaim marketshare this year

BY Michael Johnsen

NEW BRUNSWICK, N.J. — Johnson & Johnson expects to return about 75% of its OTC brands to the marketplace over the course of 2013, Alex Gorsky, J&J chairman and CEO told analysts Tuesday. "I’m very pleased with the progress that we’re making in that," he said. "We mentioned to you that the consent decree that we had designed in conjunction with the FDA was approved and reviewed in October, with very few comments. And given the breadth and scale of that agreement, we felt very good about that. We’ve had teams working hard since then. We’ve achieved all of our major milestones since we’ve submitted that agreement."

Over the past six months, J&J’s OTC division McNeil Consumer Health has been bringing brands like Children’s Tylenol and Children’s Motrin back to market. "If you look at some of the consumer ratings, the quality of those brands, we’ve seen them [as] remarkably resilient through this period," Gorsky said. "And when we get them back to the market, we see an uptake occur."

Leading the charge in managing McNeil’s comeback is Sandy Peterson, who assumed her role last month. "[She] is focusing on returning our consumer segment to growth together with Jesse Wu, our worldwide chairman of the consumer group and his leadership team," Gorsky said. 

In addition to ensuring that there is adequate supply to feed the mass retail supply chain, McNeil in 2013 will begin to shift its focus on relaunching the brands "working with our trade partners, working with our great marketing teams, to reestablish those brands and their leadership positions in the market," Gorsky said. "And we’ll do that as the brands reenter over the course of 2013."


Find us on Facebook for more insight, analysis and the latest in drug store news.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Perrigo launches private label equivalent to Nicorette mini lozenge

BY Michael Johnsen

ALLEGAN, Mich. — Perrigo on Tuesday announced that it has begun shipments of over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor), comparable to GlaxoSmithKline’s Nicorette mini lozenge. 

"This launch strengthens Perrigo’s leading store brand position in smoking cessation products, which also includes coated and uncoated flavored gums and regular size lozenges," stated Joseph Papa, Perrigo’s chairman, president and CEO. 

Nicorette Mini Lozenge is selling at an annual rate estimated at more than $30 million at all retail outlets, Perrigo stated.


Find us on Facebook for more insight, analysis and the latest in drug store news.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?